BG104338A - Composition of lipid-reducing forms - Google Patents
Composition of lipid-reducing formsInfo
- Publication number
- BG104338A BG104338A BG104338A BG10433800A BG104338A BG 104338 A BG104338 A BG 104338A BG 104338 A BG104338 A BG 104338A BG 10433800 A BG10433800 A BG 10433800A BG 104338 A BG104338 A BG 104338A
- Authority
- BG
- Bulgaria
- Prior art keywords
- lipid
- reducing
- composition
- smelt
- time
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 241001062472 Stokellia anisodon Species 0.000 abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 238000001125 extrusion Methods 0.000 abstract 1
- 235000012054 meals Nutrition 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920003169 water-soluble polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97203407 | 1997-11-03 | ||
| PCT/EP1998/006998 WO1999022738A1 (en) | 1997-11-03 | 1998-10-27 | Compositions of lipid lowering agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG104338A true BG104338A (en) | 2000-12-29 |
Family
ID=8228898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG104338A BG104338A (en) | 1997-11-03 | 2000-04-14 | Composition of lipid-reducing forms |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6342245B1 (et) |
| EP (1) | EP1028730B1 (et) |
| JP (1) | JP2001521899A (et) |
| KR (2) | KR20010023729A (et) |
| CN (1) | CN1278175A (et) |
| AR (1) | AR013739A1 (et) |
| AT (1) | ATE216238T1 (et) |
| AU (1) | AU746890B2 (et) |
| BG (1) | BG104338A (et) |
| BR (1) | BR9814109A (et) |
| CA (1) | CA2307097A1 (et) |
| DE (1) | DE69804994D1 (et) |
| EE (1) | EE200000186A (et) |
| HU (1) | HUP0004139A3 (et) |
| NO (1) | NO20002279D0 (et) |
| NZ (1) | NZ503413A (et) |
| PL (1) | PL340305A1 (et) |
| SK (1) | SK5972000A3 (et) |
| WO (1) | WO1999022738A1 (et) |
| ZA (1) | ZA989997B (et) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2450957A1 (en) | 2001-06-22 | 2003-01-03 | Pfizer Products Inc. | Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| US20030059487A1 (en) * | 2001-09-21 | 2003-03-27 | Niazi Sarfaraz K. | Composition and method for the treatment of hypercholesterolemia and hyperlipidemia in mammals |
| US6455557B1 (en) | 2001-11-28 | 2002-09-24 | Elan Pharmaceuticals, Inc. | Method of reducing somnolence in patients treated with tizanidine |
| US20040220240A1 (en) * | 2001-11-28 | 2004-11-04 | Pellegrini Cara A. | Method of increasing the extent of absorption of tizanidine |
| AU2004275826A1 (en) * | 2003-09-26 | 2005-04-07 | Alza Corporation | OROS push-stick for controlled delivery of active agents |
| KR20060092255A (ko) * | 2003-09-26 | 2006-08-22 | 알자 코포레이션 | 고도의 약물적재를 제공하는 약물코팅제 및 그의 제조방법 |
| US20050158382A1 (en) * | 2003-09-26 | 2005-07-21 | Evangeline Cruz | Controlled release formulations of opioid and nonopioid analgesics |
| MXPA06003452A (es) * | 2003-09-26 | 2006-08-31 | Johnson & Johnson | Formulaciones de liberacion controlada que exhiben una velocidad de liberacion ascendente. |
| PL1683524T3 (pl) | 2003-11-14 | 2011-06-30 | Ea Pharma Co Ltd | Stała dyspersja lub preparat farmaceutyczny stałej dyspersji pochodnej fenyloalaniny |
| AU2005230397B2 (en) * | 2004-04-09 | 2010-04-08 | Elanco Animal Health Ireland Limited | Intermittent dosing regimen for the treatment of overweight with MTP-inhibitors |
| WO2005117834A1 (en) * | 2004-05-27 | 2005-12-15 | Janssen Pharmaceutica N.V. | Solid dispersions of a basic drug compound and a polymer containing acidic groups |
| US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
| KR100582347B1 (ko) * | 2004-12-30 | 2006-05-22 | 한미약품 주식회사 | 3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법 |
| JP2008542255A (ja) * | 2005-05-27 | 2008-11-27 | ファイザー・プロダクツ・インク | 肥満症の治療または体重減量の維持のためのカンナビノイド−１受容体アンタゴニストおよびミクロソームトリグリセリド輸送タンパク質阻害物質の併用 |
| PT1912626T (pt) * | 2005-08-08 | 2016-07-20 | Abbvie Deutschland | Formas farmacêuticas com biodisponibilidade melhorada |
| EP1938804A1 (en) * | 2006-12-22 | 2008-07-02 | Novartis AG | Pharmaceutical formulation comprising neurokinin antagonist |
| DE102008047910A1 (de) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
| WO2010143199A1 (en) | 2009-06-11 | 2010-12-16 | Suven Nishtaa Pharma Private Limited | Solid lipid dispersion for aqueous solubility enhancement of poorly water soluble drugs |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5521186A (en) * | 1994-10-27 | 1996-05-28 | Janssen Pharmaceutica N.V. | Apolipoprotein-β synthesis inhibitors |
| DE122007000005I2 (de) * | 1994-10-27 | 2008-04-24 | Janssen Pharmaceutica Nv | Apolipoprotein-b syntheseinhibitoren |
-
1998
- 1998-10-27 SK SK597-2000A patent/SK5972000A3/sk unknown
- 1998-10-27 DE DE69804994T patent/DE69804994D1/de not_active Expired - Lifetime
- 1998-10-27 KR KR1020007002383A patent/KR20010023729A/ko not_active Ceased
- 1998-10-27 US US09/530,170 patent/US6342245B1/en not_active Expired - Fee Related
- 1998-10-27 CA CA002307097A patent/CA2307097A1/en not_active Abandoned
- 1998-10-27 HU HU0004139A patent/HUP0004139A3/hu unknown
- 1998-10-27 NZ NZ503413A patent/NZ503413A/en unknown
- 1998-10-27 EE EEP200000186A patent/EE200000186A/et unknown
- 1998-10-27 CN CN98810808A patent/CN1278175A/zh active Pending
- 1998-10-27 JP JP2000518671A patent/JP2001521899A/ja not_active Withdrawn
- 1998-10-27 KR KR1020007002314A patent/KR20010023661A/ko not_active Withdrawn
- 1998-10-27 EP EP98954483A patent/EP1028730B1/en not_active Expired - Lifetime
- 1998-10-27 AT AT98954483T patent/ATE216238T1/de not_active IP Right Cessation
- 1998-10-27 BR BR9814109-0A patent/BR9814109A/pt not_active IP Right Cessation
- 1998-10-27 AU AU11576/99A patent/AU746890B2/en not_active Ceased
- 1998-10-27 PL PL98340305A patent/PL340305A1/xx unknown
- 1998-10-27 WO PCT/EP1998/006998 patent/WO1999022738A1/en not_active Ceased
- 1998-11-02 ZA ZA9809997A patent/ZA989997B/xx unknown
- 1998-11-02 AR ARP980105502A patent/AR013739A1/es not_active Application Discontinuation
-
2000
- 2000-04-14 BG BG104338A patent/BG104338A/xx unknown
- 2000-04-28 NO NO20002279A patent/NO20002279D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9814109A (pt) | 2000-10-03 |
| CN1278175A (zh) | 2000-12-27 |
| CA2307097A1 (en) | 1999-05-14 |
| ZA989997B (en) | 2000-05-02 |
| AU1157699A (en) | 1999-05-24 |
| US6342245B1 (en) | 2002-01-29 |
| EP1028730B1 (en) | 2002-04-17 |
| HUP0004139A3 (en) | 2002-03-28 |
| WO1999022738A1 (en) | 1999-05-14 |
| SK5972000A3 (en) | 2000-12-11 |
| JP2001521899A (ja) | 2001-11-13 |
| AU746890B2 (en) | 2002-05-02 |
| EE200000186A (et) | 2001-04-16 |
| NZ503413A (en) | 2001-06-29 |
| NO20002279L (no) | 2000-04-28 |
| KR20010023661A (ko) | 2001-03-26 |
| EP1028730A1 (en) | 2000-08-23 |
| ATE216238T1 (de) | 2002-05-15 |
| PL340305A1 (en) | 2001-01-29 |
| NO20002279D0 (no) | 2000-04-28 |
| KR20010023729A (ko) | 2001-03-26 |
| AR013739A1 (es) | 2001-01-10 |
| DE69804994D1 (de) | 2002-05-23 |
| HUP0004139A2 (hu) | 2002-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG104338A (en) | Composition of lipid-reducing forms | |
| EA200100024A1 (ru) | Состав таблетки с делавирдином | |
| MY123827A (en) | Antifungal compositions with improved bioavailability | |
| AU1339095A (en) | Laxative compositions containing bulk fiber and dioctyl sulfosuccinate | |
| UA34428C2 (uk) | Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки | |
| BG105564A (en) | Galantamine-containing composition with controlled release | |
| BG104276A (en) | Composites of paper with polymer coating | |
| CA2253797A1 (en) | Luminous or fluorescent artificial stone composition | |
| ZA200104708B (en) | Dispersions of silyl-terminated polymers with a high solids content, their production and their use. | |
| NZ510254A (en) | Novel composition and use | |
| BR9713952A (pt) | Composição de moldagem de polìmero, e, artigo de formação termoplástica. | |
| BG102215A (en) | Compounds and pharmaceutical compositions containing them | |
| AU2002221702A1 (en) | Pharmaceutical compositions | |
| MY132550A (en) | Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists | |
| AU4080097A (en) | Piperazino derivatives as neurokinin antagonists | |
| MY120550A (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions. | |
| EP0939104A3 (en) | Rubber composition | |
| AU1100897A (en) | Stabilized antisun compositions | |
| AU5493298A (en) | Stabilized pharmaceutical compositions and process for the preparation thereof | |
| AU8595791A (en) | Galactomannan derivatives for coating or embedding medicinally active substances | |
| AU5277396A (en) | Hydraulic cement | |
| BG103412A (en) | Stabilized pharmaceutical compositions based on chinupristine and dalfopristine and their preparation | |
| DE69313634D1 (de) | Elastosole sowie deren herstellung, verwendung und produkte | |
| AU2496288A (en) | Poly-1-butene resin composition and water-proof sheet produced from the composition | |
| BG104222A (en) | Novel carboxylic acid derivatives, their production and their use as mixed eta/etb endothelin-receptor antagonists |